Evidence map›Paper›PMID 41581152›Full record

ReviewCell reports2026

Oncogenic influences of neurotrophin receptors: Shedding light on Trk biology.

Hawa L Jagana, Maryam M Shabar, Taylor S Jackson, David E Johnson, John M Hemenway, Visakha Mukkamala, Aleksandra Lukasik, Matthew R Hathaway, Siobhan S Pattwell

Abstract readReview
In one paragraph

Review in Cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hawa L JaganaNeuroscience Graduate Program, School of Medicine, Oregon Health & Science University, Portland, OR 97239, USA.
Maryam M ShabarBen Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Taylor S JacksonDoctor of Medicine Program, Morehouse School of Medicine, Atlanta, GA 30314, USA.
David E JohnsonBen Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.
John M HemenwayBen Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Visakha MukkamalaBen Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA 98101, USA; Department of Mathematics, University of Washington, Seattle, WA 98195, USA.
Aleksandra LukasikBen Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA 98101, USA; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Matthew R HathawayBen Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Siobhan S PattwellBen Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle, WA 98101, USA; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. Electronic address: siobhan.pattwell@seattlechildrens.org.

Funding

Characterizing an alternatively spliced NTRK2 isoform in development and cancerK22CA258953 · NCI · SEATTLE CHILDREN'S HOSPITAL · PI PATTWELL, SIOBHAN · 2021 to 2023
$637k
NCI NIH HHS K22 CA258953
6 · The paper itself

Abstract

During critical stages of neurodevelopment, tropomyosin receptor kinase receptors, encoded by NTRK genes, exhibit temporally driven differential peaks of expression to properly guide the establishment of the peripheral and central nervous systems. In addition, these neuronal systems exhibit non-canonical regulation of surrounding tissues, impacting organogenesis, homeostasis, plasticity, and regeneration. The same processes that guide neurodevelopment, such as differentiation, plasticity, and neuronal survival, are also hijacked in cancer, making the NTRK family an ideal candidate to study. The Trk receptor family plays a critical role in both normal development and several cancer hallmark pathways such as anti-apoptotic signaling, abnormal cellular proliferation, metastasis, and stemness. It is paramount to understand the molecular underpinnings that Trk receptors play in driving malignancy and the specificity of current therapeutics. This review explores key implications of the NTRK gene family in the pathophysiological mechanisms driving cancers within and outside the central nervous system.

Indexed as

NeoplasmsReceptors, Nerve Growth FactorAnimalsHumansNeurodevelopmentSignal TransductionReceptors, Nerve Growth Factorcancer biologyCP: cancerCP: neuroscienceneurodevelopmentneuroscienceneurotrophinsNTRKsoncology

Identifiers

PMID41581152
PMCPMC13141818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.